Sima Cahsai, NP
Nurse Practitioner · San Francisco
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 3
- 1 carrier
- Offices
- 2
- Since medical school
- 4 years
- Graduated 2022
Offices
2 locations · Regents of the University of California · Cor Healthcare Medical Associates
Looking this up.
Hospitals listed: Torrance Memorial Medical Center. That is not proof they admit you there this week.
Plans that list them
3 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Sima Cahsai’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Torrance Memorial Medical CenterTorrance, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of Cedars Sinai Health System, which runs 4 hospitalsPatients rate it 3 of 5 · 82% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — CMS Medicare PSI 90: Patient safety and adverse events composite: 1.36 (1.11 to 1.61), Jul 2022 – Jun 2024Worse than the national rate — Postoperative respiratory failure rate: 15.79 (10.51 to 21.07) · 1,494 cases, Jul 2022 – Jun 2024Worse than the national rate — Pressure ulcer rate: 1.21 (0.72 to 1.71) · 9,154 cases, Jul 2022 – Jun 2024Better than the national rate — Clostridium Difficile (C.Diff): 0.328, Oct 2024 – Sep 2025
See every measure and the patient survey for Torrance Memorial Medical Center
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 4 the same, 1 worse of 8 measures. Readmissions: 0 better, 8 the same, 3 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.36 (1.11 to 1.61) | Worse | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 15.79 (10.51 to 21.07) · 1,494 cases | Worse | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 1.21 (0.72 to 1.71) · 9,154 cases | Worse | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0.328 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.85 (0 to 1.72) · 2,154 cases | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 171.72 (128.91 to 214.54) · 121 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.2 · 36 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8 · 136 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.3 · 176 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 7.8 · 766 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 12.4 · 806 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.5 · 608 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.8 · 7,587 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.28 (0.1 to 0.47) · 11,109 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.03 to 0.39) · 11,330 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.13 (2.41 to 5.85) · 2,964 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.64 (0.13 to 3.16) · 1,513 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.66 (1.3 to 4.01) · 2,802 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.24 (2.35 to 8.14) · 1,479 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.55 (0.11 to 2.98) · 650 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 2 · 962 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.023 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.646 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.751 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 1.259 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.658 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.1 · 300 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.2 · 1,578 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 21.1 · 183 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 1.5 · 900 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 27.9 · 800 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19.1 · 1,223 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.3 (3.3 to 8.3) · 26 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.5 (7 to 15) · 26 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 928 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 12 · 65 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21 · 316 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.3 (9.5 to 16.1) · 624 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 781 cases | No different | Jan 2024 – Dec 2024 |
What patients said (2,607 patients answered, 26% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 74% |
| Nurses "always" communicated well | 78% |
| Doctors "always" communicated well | 78% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 83% |
| Doctors "always" explained things so they could understand | 73% |
| Doctors "always" listened carefully | 77% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 78% |
| Staff "always" explained new medications | 73% |
| Nurses "always" explained things so they could understand | 74% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 51% |
| "YES", patients would definitely recommend the hospital | 82% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$2,593
Medicare paid this office $2,593 for 45 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 18 | $928 | $44 |
| Return visit (30+ min) | 13 | $836 | $64 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 24 | $132 | $6 |
Who their Medicare patients are
45 Original Medicare patients in 2024. Average age 79 · Women 60% · Health risk score 1.60. Above the middle of the specialty; the typical nurse practitioner clinician is at 1.42.
Conditions among them: High blood pressure 75% · Atrial fibrillation 73% · Coronary heart disease 44% · Heart failure 44% · Chronic kidney disease 33%.
The office billed $9,169, Medicare allowed $3,310 and paid $2,593; for 68 services of 8 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Drugs they prescribed that Part D paid
$712,412
Pharmacies billed $712,412 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 1,417) in 2024. At or below the middle of the specialty; the typical nurse practitioner clinician is at 0%.
817 generic and 600 brand-name prescriptions · $712,412 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 324 | $394,330 | $1,217 |
| Jardiance | 153 | $183,977 | $1,202 |
| Xarelto | 57 | $54,517 | $956 |
| Entresto | 37 | $46,612 | $1,260 |
| Metoprolol | 156 | $2,405 | $15 |
See all 21 drugs
| Eliquis | 324 | $394,330 | $1,217 |
| Jardiance | 153 | $183,977 | $1,202 |
| Xarelto | 57 | $54,517 | $956 |
| Entresto | 37 | $46,612 | $1,260 |
| Metoprolol | 156 | $2,405 | $15 |
| Amiodarone | 46 | $1,770 | $38 |
| Diltiazem 24hr Er (Cd) | 24 | $606 | $25 |
| Atorvastatin | 58 | $487 | $8 |
| Diltiazem | 12 | $434 | $36 |
| Amlodipine Besylate | 50 | $413 | $8 |
| Hydralazine | 21 | $389 | $19 |
| Spironolactone | 50 | $382 | $8 |
| Rosuvastatin | 18 | $358 | $20 |
| Potassium Chloride | 14 | $321 | $23 |
| Metoprolol | 53 | $319 | $6 |
| Valsartan | 17 | $315 | $19 |
| Furosemide | 73 | $311 | $4 |
| Carvedilol | 42 | $265 | $6 |
| Ezetimibe | 14 | $205 | $15 |
| Losartan | 22 | $163 | $7 |
| Lisinopril | 13 | $91 | $7 |
Year by year
| 2024 | 1,417 | 413 | 0% (0) | 42% | $712,412 |
| 2023 | 378 | 153 | 0% (0) | 27% | $124,086 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 10 drugs
| Eliquis | 52 | $71,936 | $1,383 |
| Xarelto | 26 | $19,831 | $763 |
| Metoprolol | 29 | $1,091 | $38 |
| Amiodarone | 26 | $966 | $37 |
| Atorvastatin | 16 | $442 | $28 |
| Diltiazem 24hr Er (Cd) | 11 | $404 | $37 |
| Metoprolol | 13 | $179 | $14 |
| Amlodipine Besylate | 17 | $167 | $10 |
| Valsartan | 11 | $115 | $10 |
| Furosemide | 18 | $107 | $6 |
Money from drug and device companies
$888 in 2025
| 2025 | 14 | 38 | None | $888 |
| 2024 | 11 | 37 | None | $896 |
| 2023 | 9 | 15 | None | $562 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Novartis Pharmaceuticals | Leqvio | $228 | 12 payments
|
| Bayer Healthcare Pharmaceuticals | Kerendia | $167 | 3 payments
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $102 | 8 payments
|
| Inspire Medical Systems | Inspire | $83 | 2 payments
|
| Boston Scientific | Watchman Flx | $51 | 2 payments
|
| Merck Sharp & Dohme | Verquvo | $51 | 2 payments
|
See all 38 published payments
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-11-14 | Jardiance | $29 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-11-12 | Kerendia | $20 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Meals · 2025-11-04 | Lifevest | $23 |
| Novartis Pharmaceuticals | Meals · 2025-10-27 | Leqvio | $25 |
| Merck Sharp & Dohme | Meals · 2025-10-16 | Verquvo | $25 |
| Novartis Pharmaceuticals | Meals · 2025-10-10 | Leqvio | $1 |
| Novartis Pharmaceuticals | Meals · 2025-10-10 | Leqvio | $24 |
| Novartis Pharmaceuticals | Meals · 2025-10-10 | Leqvio | $3 |
| Heartflow | Meals · 2025-10-08 | Ffrct | $28 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-09-29 | Kerendia | $22 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-09-25 | Kerendia | $125 |
| Inspire Medical Systems | Meals · 2025-09-10 | Inspire | $27 |
| Novartis Pharmaceuticals | Meals · 2025-08-20 | Leqvio | $26 |
| Novartis Pharmaceuticals | Meals · 2025-08-20 | Leqvio | $26 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Meals · 2025-08-19 | Lifevest | $13 |
| Novartis Pharmaceuticals | Meals · 2025-08-11 | Leqvio | $20 |
| Boston Scientific | Meals · 2025-07-31 | Watchman Flx | $31 |
| Merck Sharp & Dohme | Meals · 2025-07-30 | Verquvo | $26 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Meals · 2025-07-28 | Lifevest | $16 |
| Kestra Medical Technology Services | Meals · 2025-07-10 | Assure Wcd | $14 |
| Inspire Medical Systems | Meals · 2025-07-09 | Inspire | $56 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Meals · 2025-07-01 | Lifevest | $15 |
| Novartis Pharmaceuticals | Meals · 2025-06-20 | Leqvio | $21 |
| Lantheus Medical Imaging | Meals · 2025-06-12 | Definity | $38 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Meals · 2025-06-11 | Lifevest | $5 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Meals · 2025-06-11 | Lifevest | $3 |
| Recor Medical | Meals · 2025-05-16 | Paradise Ultrasound Renal Denervation System | $22 |
| Novartis Pharmaceuticals | Meals · 2025-05-13 | Leqvio | $21 |
| Amgen | Meals · 2025-05-07 | Repatha | $20 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-05-06 | Wainua | $20 |
| AltaThera Pharmaceuticals | Meals · 2025-04-30 | Sotalol Hydrochloride | $18 |
| Novartis Pharmaceuticals | Meals · 2025-04-22 | Leqvio | $24 |
| Novartis Pharmaceuticals | Meals · 2025-03-21 | Leqvio | $14 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Meals · 2025-03-19 | Lifevest | $13 |
| Amgen | Meals · 2025-02-28 | Repatha | $18 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Meals · 2025-02-04 | Lifevest | $13 |
| Novartis Pharmaceuticals | Meals · 2025-01-28 | Leqvio | $22 |
| Boston Scientific | Meals · 2025-01-13 | Watchman Flx | $20 |
See earlier years (2024, 2023)
2024: $896
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $199 | 7 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $184 | 5 payments
|
| Novartis Pharmaceuticals | Leqvio | $112 | 5 payments
|
| Kiniksa Pharmaceuticals International plc | Arcalyst | $109 | 5 payments
|
| Amgen | Repatha | $92 | 5 payments
|
| Alnylam Pharmaceuticals | Amvuttra | $48 | 2 payments
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $40 | 2 payments
|
| iRhythm Technologies | Zio Monitor | $36 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Camzyos | $28 | 2 payments
|
| Janssen Pharmaceuticals | Xarelto | $26 | 1 payment
|
| Abiomed | Impella | $23 | 1 payment
|
2023: $562
| Impulse Dynamics (USA) | Optimizer | $167 | 1 payment
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $152 | 3 payments
|
| Alnylam Pharmaceuticals | Amvuttra | $68 | 3 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $44 | 2 payments
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $37 | 2 payments
|
| Boston Scientific | Wavewriter Alpha Prime 16 | $26 | 1 payment
|
| Kiniksa Pharmaceuticals | Arcalyst | $25 | 1 payment
|
| Merck Sharp & Dohme | Verquvo | $22 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Camzyos | $21 | 1 payment
|
Professional record
- NPI
- 1356059216
- Licence
- CA 95021733
- Group
- Regents of the University of California · Cor Healthcare Medical Associates
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 363LA2100X (363LA2100X); Federal specialty code 363LG0600X (363LG0600X)
- Mailing address
- 3214 S Barrington Ave Apt E, Los Angeles, CA, 90066
- NPI first listed
- 2022-11-09
- NPI last updated
- 2025-10-16
- NPI record certified
- 2025-10-16
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 2841 Lomita Blvd Ste 100, Torrance, CA, 90505